See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Eid
Natural Disasters
Social Media
Artificial Intelligence
Tariffs
Donald Trump
Stock Markets
UK Economy
European Union
Vladimir Putin
Inflation
Soccer
Published • loading... • Updated

United Health Products Provides Update on FDA and OTC Markets Applications

Summary by The Business Times
MT. LAUREL, NJ – March 28, 2025 ( NEWMEDIAWIRE ) – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities. As previously disclosed, the FDA requested that certain additional sterilization and biotoxicity tests be included in the company’s Investigational Device Exemption (IDE) application. An IDE approval is a precondition to commencing the enrollment of 27 patients in UHP’s…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All
Left
Center
Right
NewMediaWireNewMediaWire
Reposted by
The Business TimesThe Business Times

United Health Products Provides Update on FDA and OTC Markets Applications

MT. LAUREL, NJ - March 28, 2025 (NEWMEDIAWIRE) - United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s regulatory and capital markets activities.   As previously disclosed, the FDA requested that certain additional sterilization and biotoxicity tests be included in the company’s Investigational Device Exemption (IDE) application. An IDE approval is a precondition to commencing the enrollment of 27 patients in UHP’s…

Read Full Article
citybuzz.cocitybuzz.co

United Health Products Advances FDA Review for CelluSTAT Hemostatic Gauze

United Health Products has successfully completed additional sterilization and biotoxicity tests for its medical device, CelluSTAT Hemostatic Gauze, marking a significant step forward in its FDA approval process. The company submitted comprehensive test results confirming the product meets safety requirements for a Class III, absorbable medical device. The FDA previously requested supplemental tests as part of the Investigational Device Exemptio…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

citybuzz.co broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)

Similar News Topics

FDA

FDA

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal